March 29 (Reuters) - Frequency Therapeutics Inc FREQ.O :
* FREQUENCY THERAPEUTICS PROVIDES BUSINESS UPDATES AND
REPORTS
FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* FREQUENCY THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.30
* FREQUENCY THERAPEUTICS INC - QTRLY REVENUE $10 MILLION
VERSUS
$4.7 MILLION
* FREQUENCY THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS ON DEC. 31, 2020 WERE $220.3 MILLION
* FREQUENCY THERAPEUTICS INC - EXPECTS EXISTING CASH AND
CASH
EQUIVALENTS, AND SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO
FUND OPERATIONS INTO 2023
Source text for Eikon: ID:nBw88pk8Da
Further company coverage: FREQ.O
((Reuters.Briefs@thomsonreuters.com;))